Nov 30 Risk of COVID-19 scams as vaccine approaches FDA approval By Colleen Long, Associated Press The coronavirus vaccine inching toward approval in the U.S. is desperately anticipated by Americans longing for a path back to normal life. But criminals are waiting, too. They're ready to use that desperation to their advantage. Continue reading
Nov 19 Pfizer to seek emergency coronavirus vaccine approval By Associated Press Pharmaceutical companies Pfizer and BioNTech will seek emergency government approval for their coronavirus vaccine, as the U.S. aims to begin administering doses by the end of the year. Continue reading
Nov 16 Watch 9:06 What we know about Moderna’s COVID-19 vaccine candidate — and what we don’t The drug company Moderna has released encouraging data from research on its COVID-19 vaccine candidate. The research has not yet been published in a peer-reviewed medical journal, but it is nonetheless raising hopes. Noubar Afeyan is a co-founder and chairman… Continue watching
Nov 16 Watch 6:37 The risks and rewards of Operation Warp Speed’s approach to vaccines By Miles O'Brien The race to develop vaccine candidates to prevent COVID-19 represents an unprecedented national and global effort. President Trump and some public health experts say encouraging early results from Pfizer and Moderna suggest the approach is working. But there are also… Continue watching
Nov 09 Pfizer says COVID-19 vaccine is looking 90 percent effective By Associated Press “We’re in a position potentially to be able to offer some hope,” Dr. Bill Gruber, Pfizer’s senior vice president of clinical development, told The Associated Press. “We’re very encouraged.”… Continue reading
Nov 09 Global markets rocket higher amid vaccine news and U.S. election By Associated Press Markets were already sharply higher on the U.S. election result when Pfizer said that data shows vaccine shots may be 90% effective at preventing COVID-19. Continue reading
Oct 22 WATCH: FDA advisory committee assesses COVID-19 vaccine development By Helen Branswell, STAT This week's meeting, while likely dry and technical, "shows the public that this is how FDA is going about its decisions," one expert said. Continue reading
Oct 19 Coronavirus vaccine storage issues could leave 3 billion people without access By Associated Press From factory to syringe, the world’s most promising coronavirus vaccine candidates need non-stop sterile refrigeration to stay potent and safe. Continue reading
Oct 09 Why Americans have grown more hesitant about the COVID-19 vaccine By Laura Santhanam Polarizing U.S. politics are fueling division over a COVID-19 vaccine, which is the one thing that can help the planet regain control and restore a semblance of normality, public health experts say. Continue reading
Oct 01 Push to bring coronavirus vaccines to those in poverty faces trouble By Maria Cheng, Lori Hinnant, Associated Press In one of the biggest obstacles, rich countries have locked up most of the world's potential vaccine supply through 2021, and the U.S. and others have refused to join the project, called Covax. Continue reading